Press Releases about Arrowhead Pharmaceuticals, Inc. - Common Stock![]() ![]() ![]() ![]() ![]() ![]() ![]()
Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study
July 02, 2021
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Arrowhead Earns $10 Million Option Exercise Fee
May 18, 2021
Via Business Wire
![]() ![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|